Skip to content

Clinical trials

Phase 2 Asthma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Phase: Phase 2 Country / region: Australia Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20071
20081
20091
20103
20124
20133
20141
20151
20171
20211
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated5
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
AstraZeneca3
Amgen2
Genentech, Inc.2
Hoffmann-La Roche2
Boehringer Ingelheim1
Connect Biopharm LLC1
Humanigen, Inc.1
Idorsia Pharmaceuticals Ltd.1
MedImmune LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma25
Aspergillosis, Allergic Bronchopulmonary1
Bronchial Diseases1
Dermatitis, Atopic1
Disease1
Eczema1
Food Hypersensitivity1
Lung Diseases1
Respiratory Tract Diseases1
Respiratory Tract Infections1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.